rs368031148
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_178452.6(DNAAF1):c.361C>A(p.Arg121Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.361C>A | p.Arg121Ser | missense_variant | 4/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.361C>A | p.Arg121Ser | missense_variant | 4/12 | 1 | NM_178452.6 | ENSP00000367815.5 | ||
DNAAF1 | ENST00000567918.5 | n.361C>A | non_coding_transcript_exon_variant | 4/7 | 1 | ENSP00000455154.1 | ||||
DNAAF1 | ENST00000563093.5 | n.361C>A | non_coding_transcript_exon_variant | 4/11 | 2 | ENSP00000457373.1 | ||||
DNAAF1 | ENST00000570298.5 | n.515C>A | non_coding_transcript_exon_variant | 4/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152100Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461716Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727184
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74416
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2017 | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with DNAAF1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with serine at codon 121 of the DNAAF1 protein (p.Arg121Ser). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and serine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.361C>A (p.R121S) alteration is located in exon 4 (coding exon 4) of the DNAAF1 gene. This alteration results from a C to A substitution at nucleotide position 361, causing the arginine (R) at amino acid position 121 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at